AFP is the most widely used serum biomarker for HCC diagnosis and HCC surveillance using ultrasound and AFP at semiannual intervals is recommended in the American Association for the Study of Liver Diseases (AASLD) guideline [40]. This evidence concerns the gene AFP and hepatocellular carcinoma.